AZN vs CDLX · P/E 28, $288.38B cap vs rev $71.2M
AstraZeneca PLC (AZN) versus Cardlytics Inc (CDLX) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Cardlytics Inc (CDLX) is a advertising agencies company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported CDLX revenue for 2026-06-30 was $71.2M. Net income was -$19.4M. CDLX currently screens at market cap $95.0M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. CDLX currently screens at market cap $95.0M.
Not investment advice. Open the AZN and CDLX stock pages for the full models.
Not investment advice.